Molecular Testing in Trouble from Medicare. Who’s on First?

2020-02-28T16:04:34+00:00April 23rd, 2013|Categories: Blog|Tags: , , , |

Only a Bureaucracy as Inefficient and Unwieldy as Medicare Could Create a Mess This Bad and Then Walk Away Whistling, Hands in Pockets I’m referring to Medicare’s decision to stop paying bills for molecular testing and other diagnostic tests that are transforming the way many life-threatening diseases are being treated.  This is a decision affecting hundreds of labs, including labs performing proprietary tests that target treatments for cancer patients [...]